Chemotherapy

Many a time treatment of cancer can be expensive enough, especially when the treatment period is prolonged involving chemotherapy. Study by the “Disease Control & Prevention” of US centers reveal that 1 in every 5 person gets the required cancer treatment done late or stay away from the treatment getting done. This study was based amongst the cancer survivors below the age of 65. This stands factual amongst the uninsured, and also with medical cover the monetary brunt can be substantial for the patients having cancer.

A nationwide survey among 52000 persons revealed that the problem is much complex for persons surviving from cancers, than other types of patients. When evaluated amongst 21% of persons surviving from cancer, 12% of the persons having further health difficulties have found the treatment very costly to believe.

Few chemotherapeutic drugs are reasonably within reach in price, like leucovorin and 5-FU. Latest anticancer drugs cost are high, moreover whenever blended and used. The drug cost while treating with leucovorin and 5-FU for 8 weeks would be approximately $100 to $300, and with the addition of irinotecan or oxaliplatin, the cost would rise to $10,000 approximately. Again addition of cetuximab (Erbitux) or bevacizumab (Avastin), would further take the expenditure to $20,000 to $30,000. All these are only the expenditure for the drugs. For your planning, please enquire about other expenditures too.

As the treatment extends the survival only by few months, this has some troubling issue for the patients, respective doctors, and the society. As per “The-New-England-Journal-of-Medicine” – the newer drugs arriving in the market place with high price would result in rise in policy premiums and other allied subjects, and would become nearly impossible to afford even for comparatively affluent persons. To accomplish a short-term advantage many person by means of other medical provisions might suffer death in advance or disability, as they cannot meet up the expenses for the treatment. Our society persists to keep away from struggling with these thorny concerns of equity.

A patient of colon cancer has to bear the brunt of high expenditure, which is not hypothetical, but instantaneous for him. Mostly a delay in approval is noticed in the insurance coverage matter. Even though insurance might cover all or part of the expenditure, several policies put a ceiling on it: like a highest amount to be reimbursed to an individual over lifetime. Persons on Medicare, and exclusive of some other insurance, spend 20% of cost, which is a considerable amount.

By any means if the chemotherapy cost is exorbitantly high, then a verification with some pharmaceutical firms may be of some help; as they many a times support in paying for the drugs. Various committees have programs where they offer them totally free.

Traditionally chemotherapy for general malignant tumors has been treated as “very expensive”. The cancer centers at Toronto suggested that this overview is not precise. The expenditure of chemotherapeutic drugs administered on outpatient base over 4-6 months following the drug protocol, ranges $260-$5374. Per dosage cost for outpatient administration stands $152.53 approximately.